Local alendronic acid elution increases net periimplant bone formation: A micro-CT analysis

Clinical Orthopaedics and Related Research

Volumn 472, Issue 2, 2014, Pages 687-694

  Bobyn, J Dennis ^a,b   Thompson, Rebecca ^a   Lim, Letitia ^a   Pura, Jenny Ann ^a   Bobyn, Kristian ^a   Tanzer, Michael ^a,b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE IMPLANT; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DRUG EFFECT; ELUTION; EXPERIMENTAL DOG; FEMALE; FEMUR; HISTOLOGY; IMPLANT; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TISSUE SECTION;

ALENDRONATE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; COATED MATERIALS, BIOCOMPATIBLE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMUR; MALE; MODELS, ANIMAL; OSSEOINTEGRATION; POROSITY; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; TIME FACTORS; TITANIUM; X-RAY MICROTOMOGRAPHY;

EID: 84893657474     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-013-3120-6     Document Type: Conference Paper

References (20)

1. Arabmotlagh M, Pilz M, Warzecha J, Rauschmann M. Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty. J Orthop Res. 2009;27:183-188.
2. Bhandari M, Bajammal S, Guyatt GH, Griffith L, Busse JW, Schünemann H, Einhorn TA. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J Bone Joint Surg Am. 2005;87:293-301.
3. Bobyn JD, Hacking SA, Krygier JJ, Harvey EJ, Little DG, Tanzer M. Zoledronic acid causes enhancement of bone growth into porous implants. J Bone Joint Surg Br. 2005;87:416-420.
4. Bobyn JD, McKenzie K, Karabasz D, Krygier JJ, Tanzer M. Locally delivered bisphosphonate for enhancement of bone formation and implant fixation. J Bone Joint Surg. 2009;91(Suppl 6):23-31.
5. Cook RE, Jenkins PJ, Walmsley PJ, Patton JT, Robinson CM. Risk factors for periprosthetic fractures of the hip: a survivorship analysis. Clin Orthop Relat Res. 2008;466:1652-1656.
6. Friedl G, Radl R, Stihsen C, Rehak P, Aigner R, Windhager R. The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty. A randomized, double-blind, controlled trial. J Bone Joint Surg Am. 2009;91:274-281.
7. Gao Y, Zou S, Liu X, Bao C, Hu J. The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials. 2009;30:1790-1796.
8. Garbuz DS, Hu Y, Kim WY, Duan K, Masri BA, Oxland TR, Burt H, Wang R, Duncan CP. Enhanced gap filling and osteoconduction associated with alendronate-calcium phosphate-coated porous tantalum. J Bone Joint Surg Am. 2008;90:1090-1100.
9. Garcia-Moreno C, Serrano S, Nacher M, Farré M, Díez A, Mariñoso ML, Carbonell J, Mellibovsky L, Nogués X, Ballester J, Aubía J. Effect of alendronate on cultured normal human osteoblasts. Bone. 1998;22:233-239.
10. Goodship AE, Blunn GW, Green J, Coathup MJ. Prevention of strain-induced osteopenia in aseptic loosening of hip prostheses using perioperative bisphosphonate. J Orthop Res. 2008;26:693-703.
11. Hilding M, Aspenberg P. Local preoperative treatment with a bisphosphonate improves the fixation of total knee prostheses. Acta Orthop. 2007;78:795-799.
12. Jakobsen T, Baas J, Kold S, Bechtold JE, Elmengaard B, Søballe K. Local bisphosphonate treatment increases fixation of hydroxyapatite-coated implants inserted with bone compaction. J Orthop Res. 2009;27:189-194.
13. Lindahl H. Epidemiology of periprosthetic femur fracture around a total hip arthroplasty. Injury. 2007;38:651-654.
14. Papapetrou PD. Bisphosphonate-associated adverse events. Hormones. 2009;8:96-110.
15. Peter B, Gauthier O, Laib S, Bujoli B, Guicheux J, Janvier P, van Lenthe GH, Müller R, Zambelli PY, Bouler JM, Pioletti DP. Local delivery of bisphosphonate from coated orthopedic implants increases implant mechanical stability in osteoporotic rats. J Biomed Mater Res A. 2006;76:133-143.
16. Peter B, Pioletti DP, Laib S, Bujoli B, Pilet P, Janvier P, Guicheux J, Zambelli PY, Bouler JM, Gauthier O. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone. 2005;36:52-60.
17. Prieto-Alhambra B, Javaid MK, Judge A, Murray D, Carr A, Cooper C, Arden NK. Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ. 2011;343:1-9.
18. Tanzer M, Karabasz D, Krygier JJ, Cohen R, Bobyn JD. Bone augmentation around and within porous implants by local bisphosphonate elution. Clin Orthop Relat Res. 2005;441:30-39.
19. Tengvall P, Skoglund B, Askendal A, Aspenberg P. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials. 2004;25:2133-2138.
20. Yoshinari M, Oda Y, Inoue T, Matsuzaka K, Shimono M. Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants. Biomaterials. 2002;23:2879-2885.